MODERATE TO SEVERE ULCERATIVE COLITIS
Clinical trials for MODERATE TO SEVERE ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug vixarelimab tested for Tough-to-Treat ulcerative colitis
Disease control OngoingThis early-stage trial is testing a drug called vixarelimab in 24 people with moderate to severe ulcerative colitis who have not improved with standard treatments. The study looks at how the drug affects the gut, how it moves through the body, and whether it is safe. It is too ea…
Matched conditions: MODERATE TO SEVERE ULCERATIVE COLITIS
Phase: PHASE1, PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
New pill could tame severe gut disease
Disease control OngoingThis study tests a new drug called Hemay005 for people with moderate to severe ulcerative colitis, a chronic gut condition. About 92 participants will receive either a low dose, high dose, or a placebo for 12 weeks. The goal is to see if the drug can reduce symptoms like diarrhea…
Matched conditions: MODERATE TO SEVERE ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC